Ro 24-7429 Uses, Dosage, Side Effects and more
Ro 24-7429 is under investigation in clinical trial NCT00002314 (A Study of Ro 24-7429 in Patients With Hiv-related Kaposi's Sarcoma).
Trade Name | Ro 24-7429 |
Generic | Ro 24-7429 |
Type | |
Formula | C14H13ClN4 |
Weight | Average: 272.74 Monoisotopic: 272.0828741 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |